Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.5300 (6.04%) ($5.5300 - $5.5300) on Thu. Jun. 24, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.77% (three month average) | RSI | 80 | Latest Price | $5.5300(6.04%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 1.7% a day on average for past five trading days. | Weekly Trend | CAPR advances 13.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) SLV(-32%) XLU(-37%) SKYY(-13%) XLF(-44%) XLC(-45%) | Factors Impacting CAPR price | CAPR will decline at least -2.385% in a week (0% probabilities). IWD(-69%) IWM(-39%) IYT(-37%) IWN(-24%) JETS(-14%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.385% (StdDev 4.77%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $5.45(1.47%) | 10 Day Moving Average | $5.05(9.5%) | 20 Day Moving Average | $4.59(20.48%) | To recent high | -3.2% | To recent low | 9.9% | Market Cap | $109m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |